The Pharmacy Model Creating New Billing Pathways, Improved Recognition

Mark Ey, RPh, joins Over the Counter to discuss the new CMS ACCESS to Pharmacy Care program, how exactly it creates reimbursement opportunities for community pharmacies, and what this initiative means for the future of the profession.

Zaid Fadul, MD, FS, FAAFP, joins Over the Counter to discuss the first AI-powered prescribing pilot program, his role in the initiative, and what this means for the future of the pharmacist's role in health care.

Allison Schneider, MPH, joins Over the Counter to discuss how new Medicare drug price negotiations have impacted pharmacies in 2026, including how developments regarding PBM reform and 340B pricing fall in line.

Rita King, CEO and senior regulatory strategist with MethodSense, joins Over the Counter to discuss the emergence of artificial intelligence in medical device use while sharing key safety and risk management insights pharmacists should keep in mind.

Melissa McGivney, PharmD, FAPhA, FCCP, joins Over the Counter to celebrate American Pharmacists Month through exploring her organization's role in honoring pharmacists during October as well as the incredible progress the profession has made in recent years.

Brian Smith, PharmD, joins Over the Counter to explore current GLP-1 developments in the marketplace and how this therapy class is revolutionizing the way health care leaders approach medication adherence.

Jennifer Hammons, PharmD, DrPH, joins Over the Counter to discuss her experience as a pharmacist in Appalachia and why rural pharmacies across the country serve as essential public health resources.

Chad Worz, PharmD, BCGP, FASCP, joins Over the Counter to discuss the current status of the Main Street Pharmacy Access Act and what its signing could mean for the future of community pharmacy.

Vanessa Slowey joins Over the Counter to explore the growing emergence of AI, automation, and pharmacy technology, providing a nuanced discussion surrounding the future of pharmacist-led care.

Thomas Lew, MD, ABIM, Molly O’Shea, MD, FAAP, and Jesse Goodman, MD, MPH, join Over the Counter to discuss ongoing developments regarding change in federal vaccine guidance and its impact on measles outbreaks across the US.